Clinical Trial Update: Vasopressin in Traumatic Hemorrhagic Shock Study [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study evaluating vasopressin for traumatic hemorrhagic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock
• Hypovolemic Shock

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Volker Wenzel | Conditions: Shock, Hypovolemia | Phase 2, Phase 3 | Status: COMPLETED